Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

There is increasing interest in the use of cell-free circulating tumor DNA (ctDNA) as a serum marker for therapy assessment in prostate cancer patients. Prostate cancer is characterized by relatively low numbers of mutations, and, in contrast to many other common epithelial cancers, commercially ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Krumbholz, Manuela, Agaimy, Abbas, Stoehr, Robert, Burger, Maximilian, Wach, Sven, Taubert, Helge, Wullich, Bernd, Hartmann, Arndt, Metzler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930771/
https://www.ncbi.nlm.nih.gov/pubmed/31915468
http://dx.doi.org/10.1155/2019/5085373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930771/
https://www.ncbi.nlm.nih.gov/pubmed/31915468
http://dx.doi.org/10.1155/2019/5085373

Ejemplares similares